DYSTONIA 26, MYOCLONIC
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystonia.
|
25983243 |
2015 |
DYSTONIA 26, MYOCLONIC
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
DYSTONIA 26, MYOCLONIC
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Myoclonic dystonia
|
0.510 |
GermlineCausalMutation
|
disease |
ORPHANET |
The clinical presentation of the KCTD17-mutated cases was distinct from the phenotype usually observed in M-D due to SGCE mutations.
|
25983243 |
2015 |
Myoclonic dystonia
|
0.510 |
GeneticVariation
|
disease |
BEFREE |
After excluding SGCE mutations, we identified through a combination of linkage analysis and whole-exome sequencing KCTD17 c.434 G>A p.(Arg145His) as the only segregating variant in a dominant British pedigree with seven subjects affected by M-D. A subsequent screening in a cohort of M-D cases without mutations in SGCE revealed the same KCTD17 variant in a German family.
|
25983243 |
2015 |
Myoclonic dystonia
|
0.510 |
Biomarker
|
disease |
CTD_human |
|
|
|
Mean Corpuscular Volume (result)
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genetic Loci implicated in erythroid differentiation and cell cycle regulation are associated with red blood cell traits.
|
22560525 |
2012 |
Finding of Mean Corpuscular Hemoglobin
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genetic Loci implicated in erythroid differentiation and cell cycle regulation are associated with red blood cell traits.
|
22560525 |
2012 |
Corpuscular Hemoglobin Concentration Mean
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Seventy-five genetic loci influencing the human red blood cell.
|
23222517 |
2012 |
Anxiety
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Blepharospasm
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dysarthria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Myoclonus
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Personality Disorders
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Torticollis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Panic Attacks
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Obsessive compulsive behavior
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Laryngeal dystonia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Spinal cord myoclonus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Writer's Cramp
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Limb myoclonus
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Non-alcoholic Fatty Liver Disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
KCTD17, which is up-regulated in liver tissues of obese mice and patients with NAFLD, binds to phosphorylated PHLPP2 to target it for ubiquitin-mediated degradation; this increases expression of genes that regulate lipogenesis to promote hepatic steatosis.
|
28859855 |
2017 |
Steatohepatitis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Levels of KCTD17 mRNA were increased in livers of HFD-fed C57BL/6J or db/db obese mice and in liver biopsies patients with NAFLD, compared with liver tissues from healthy control mice or patients without steatosis.
|
28859855 |
2017 |
Dystonia
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
The novel myoclonus-dystonia genes KCTD17 and CACNA1B also implicate abnormal calcium signaling in dystonia.
|
26991507 |
2016 |